News
Company to host conference call and webcast today at 8:00 A.M. ET ...
RENSSELAER, NY, USA I June 09, 2025 I Taconic Biosciences, a global leader in providing animal model solutions and services, entered into an exclusive license ...
SUZHOU, China I June 9, 2025 I Neowise Biotechnology ("Neowise"), a pioneering company focused on the development of TCR-T cell therapies for solid tumors, ...
BOSTON, MA, USA I June 09, 2025 I Anodyne Nanotech, a clinical-stage biotech company, today announced new preclinical data demonstrating that administration ...
TAICHUNG, Taiwan I June 9, 2025 I A research team led by Dr. Der-Yang Cho, Superintendent of China Medical University Hospital (Taiwan), in collaboration with Shine-On Biomedical Co., has developed ...
NewAmsterdam Pharma Announces Positive Topline Alzheimer’s Disease Data from BROADWAY Clinical Trial
Pre-specified analyses show that obicetrapib treatment leads to statistically significant and clinically meaningful reductions in the primary outcome ...
Using AI machine learning, the Company discovers distinct biomarkers for detecting certain rare liver cancers that have stem cell characteristics and will ...
INCHEON, Korea I June 09, 2025 I Samsung Bioepis Co., Ltd. (“Samsung Bioepis”) announced today that the company has entered into a license, development and ...
SHANGHAI, China I June 9, 2025 I Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical ...
LEIDEN, The Netherlands I June 09, 2025 I Azafaros, a clinical-stage biotechnology company developing novel therapies for rare lysosomal storage disorders ...
CHENGDU, China I June 6, 2025 I Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", 6990.HK) today announced ...
In the trial, 120 patients with atopic dermatitis and skin of color (82% Black, 11% Asian, 2% American Indian/Alaska Native, 5% Arab, Central American or other) were treated with Dupixent every two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results